This is the third renewal of Chemistry-Biology Interface (CBI) training grant T32 GM08804. We have designed an interdisciplinary program for training students (and faculty) at the interface of biological, medicinal, and traditional chemistry, called the Biological Chemistry Program (BCP). The BCP began in the fall of 2000 and provides a focused, cross-disciplinary education for students at the interface of biology and chemistry. The BCP is fully integrated into the departments of Chemistry and Biochemistry (Colleges of Science and Medicine), and Pharmacology and Toxicology (Division of Drug Discovery and Development, College of Pharmacy). Students may obtain a degree in Chemistry, Biochemistry, or Pharmaceutical Sciences while following the Biological Chemistry Training Program. Students undertake graduate coursework in Chemistry and Biology, perform research rotations in at least two research disciplines, organize an annual retreat and participate in the weekly BCP Research Forum, where students and faculty present research results. Importantly, students may work with anyone in the program, regardless of departmental affiliation, allowing for true multidisciplinary research efforts. The training faculty includes 28 highly active research groups. Students remain in the BCP until graduation. There are 48 students currently following the training program, 31 of whom are training grant eligible. Of these, 16% are from an underrepresented group. Training grant slots are generally awarded for years 2 and 3 in the program, allowing training grant recipients great flexibility in assembling a multidisciplinary research project. Fellowships are awarded in May to help first- year students assemble a broad-based mentoring team. For years 15-20, we request 6 training grant slots per year. Training at the Chemistry-Biology Interface is highly relevant for advances in public health. By blending Chemistry, Medicinal Chemistry and Biochemistry, our trainees are poised to make the next breakthroughs in drug discovery, disease detection, disease prevention, and the discovery of the underlying principles governing life and disease. Our 80 BCP graduates populate both academic science centers and disease-oriented private-sector companies.

Public Health Relevance

The Biological Chemistry Program trains PhD students at the interface of Chemistry and Biology, with particular emphases on drug discovery and the underlying principles governing healthy cells. Our students are poised to make the next great discoveries in disease detection and cures.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM008804-17
Application #
9935075
Study Section
NIGMS Initial Review Group (TWD)
Program Officer
Fabian, Miles
Project Start
2003-07-01
Project End
2024-06-30
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
17
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Arizona
Department
Biochemistry
Type
Schools of Medicine
DUNS #
806345617
City
Tucson
State
AZ
Country
United States
Zip Code
85721
Dodson, Matthew; Liu, Pengfei; Jiang, Tao et al. (2018) Increased O-GlcNAcylation of SNAP29 drives arsenic-induced autophagic dysfunction. Mol Cell Biol :
Zhang, Jiantao; Hu, Yanmei; Foley, Christopher et al. (2018) Exploring Ugi-Azide Four-Component Reaction Products for Broad-Spectrum Influenza Antivirals with a High Genetic Barrier to Drug Resistance. Sci Rep 8:4653
Musharrafieh, Rami; Ma, Chunlong; Wang, Jun (2018) Profiling the in vitro drug-resistance mechanism of influenza A viruses towards the AM2-S31N proton channel blockers. Antiviral Res 153:10-22
Foley, Christopher; Shaw, Arthur; Hulme, Christopher (2018) Aza-Riley Oxidation of Ugi-Azide and Ugi-3CR Products toward Vicinal Tricarbonyl Amides: Two-Step MCR-Oxidation Methodology Accessing Functionalized ?,?-Diketoamides and ?,?-Diketotetrazoles. Org Lett 20:1275-1278
Wales, Jessica A; Chen, Cheng-Yu; Breci, Linda et al. (2018) Discovery of stimulator binding to a conserved pocket in the heme domain of soluble guanylyl cyclase. J Biol Chem 293:1850-1864
Hu, Yanmei; Zhang, Jiantao; Musharrafieh, Rami et al. (2017) Chemical Genomics Approach Leads to the Identification of Hesperadin, an Aurora B Kinase Inhibitor, as a Broad-Spectrum Influenza Antiviral. Int J Mol Sci 18:
McConnell, Nicholas; Xu, Zhigang; Kumarasamy, Vishnu et al. (2017) Synthesis of Constrained Heterocycles Employing Two Post-Ugi Cyclization Methods for Rapid Library Generation with In Cellulo Activity. ChemistrySelect 2:11821-11825
Tillotson, Joseph; Kedzior, Magdalena; Guimarães, Larissa et al. (2017) ATP-competitive, marine derived natural products that target the DEAD box helicase, eIF4A. Bioorg Med Chem Lett 27:4082-4085
Hu, Yanmei; Musharrafieh, Rami; Ma, Chunlong et al. (2017) An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses. Antiviral Res 140:45-54
Bungard, Dixie; Copple, Jacob S; Yan, Jing et al. (2017) Foldability of a Natural De Novo Evolved Protein. Structure 25:1687-1696.e4

Showing the most recent 10 out of 72 publications